Vitals, which provides pricing transparency and reviews of physicians, named Heyward Donigan as its new CEO, replacing Mitch Rothschild, while appointing former Priceline Group CEO Jeffrey Boyd to adviser and board director.
Donigan was previously CEO of ValueOptions, a health improvement company that specializes in mental and emotional well-being and recovery. There, she helped drive revenues to over $1 billion. The company was acquired by Boston-based Beacon Health Strategies late in 2014. Prior to ValueOptions, Donigan was executive vice president and chief marketing officer at Premera Blue Cross.
Boyd is chairman of The Priceline Group and served as its CEO from 2002 to 2013. Before joining Priceline, he served as executive vice president, general counsel and secretary of Oxford Health Plans.
The Power of Real World Data to Study Women’s Health at Scale
Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!
Over the past three years, Vitals said it has seen its revenue nearly quadruple as it expanded into the busy digital health and transparency space. In October last year, Vitals acquired Compass Healthcare Advisers as a way to add to its physician comparison and cost calculator tools.
Rothschild, who co-founded New Jersey-based Vitals, will continue as chairman.